Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
7,701	71.34296	0	male	0	13	386	COPD	COPD/CHF/Cirrhosis	2	10	under $11k	0	17,512	11,379.1406	12,422.2344	13	white	17.097656	31	0.843994	0.743896	4	0	0	no	0.95	0.95	no dnr	13	98	13.298828	96	20	37.19531	285.6875	4.099609	1	1.099854	136	7.389648	158	21	null	0	null	no(M2 and SIP pres)	0.494751
7,702	53.51999	1	female	0	12	265	CHF	COPD/CHF/Cirrhosis	5	9	under $11k	0	18,157	10,024	11,561.9141	33.5	white	34.796875	42	0.680908	0.511963	1	0	0	no	0.75	0.5	no dnr	12	77	7.5	101	20	35.39844	null	3.099609	0.399963	0.599976	138	null	114	9	null	6	1	adl>=4 (>=5 if sur)	1
7,703	39.75098	0	female	0	17	385	Cirrhosis	COPD/CHF/Cirrhosis	3	11	under $11k	0	19,635	13,662.0312	14,671.7891	14.666664	black	17.199219	33	0.902954	0.836914	1	0	0	no	0.9	0.7	dnr after sadm	2	106	8.798828	67	10	38	263.3125	2.599609	1	0.799927	135	7.419922	120	12	1,711	0	0	null	0
7,704	72.35596	1	female	1	24	24	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	97,395	null	null	55.333313	white	30.796875	50	0.651978	0.552979	1	0	0	no	0.3	0.3	no dnr	24	120	6.299805	80	20	36.59375	null	4.099609	1.5	1.199951	138	null	156	24	4,595	null	1	<2 mo. follow-up	1
7,705	33.58798	1	male	1	56	56	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	under $11k	0	171,848	null	null	32	black	34.898438	68	0.679932	0.584961	14	0	0	no	0.6	0.5	dnr after sadm	54	46	32.09375	61	16	35.69531	248.5625	1.599854	1.099854	5.599609	148	7.359375	172	89	0	null	7	<2 mo. follow-up	7
7,706	64.99896	1	female	0	4	174	CHF	COPD/CHF/Cirrhosis	3	11	under $11k	0	3,993	null	null	9	black	18.699219	12	0.873901	0.790894	1	0	0	no	0.8	0.7	no dnr	4	122	9.298828	120	40	36.09375	162.5	3.199707	0.299988	1.299805	140	7.439453	323	25	2,371	null	0	no(M2 and SIP pres)	0
7,707	56.86499	0	male	0	5	384	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	9	6,002	4,028.7656	4,148.75781	14	white	17.5	17	0.902954	0.836914	1	0	0	no	0.9	0.85	no dnr	5	134	5.899414	122	28	36.5	143.3125	2.5	0.599976	0.699951	139	7.479492	154	12	320	null	null	null	4.063477
7,708	48.008	0	male	0	16	384	Cirrhosis	COPD/CHF/Cirrhosis	2	8	under $11k	0	29,124	18,779.5469	21,414.1719	23.666656	white	18	20	0.869995	0.784912	1	0	0	no	0.95	0.95	no dnr	16	135	13.798828	135	40	36	350.6875	2.299805	1.799805	0.899902	147	7.439453	108	17	1,890	1	null	SIP>=30	1.166748
7,709	50.78699	0	female	0	24	384	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	>$50k	0	75,232	null	null	41	black	31.699219	51	0.736938	0.654907	1	1	0	no	0.9	0.9	no dnr	24	53	7.899414	118	20	38.69531	null	2.699707	0.299988	0.699951	137	null	128	7	2,425	null	1	null	1
7,710	52.05698	1	female	0	10	183	Lung Cancer	Cancer	1	12	$25-$50k	0	22,565	14,776.0312	16,315.3438	17.5	black	15.298828	19	0.766968	0.518921	1	0	0	metastatic	0.5	0.2	no dnr	10	50	2.799805	113	14	35.69531	294	1.799805	3	1.899902	133	7.40918	231	25	307	0	0	SIP>=30	0
7,711	71.00897	1	male	1	23	23	MOSF w/Malig	ARF/MOSF	1	6	under $11k	44	85,068	null	null	44.666657	white	26	40	0.253967	0.149994	9	0	0	metastatic	0.3	0.3	dnr after sadm	6	123	4.199219	70	24	35.89844	null	2.599609	0.699951	1.299805	137	null	151	20	null	null	0	<2 mo. follow-up	0
7,712	75.62799	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	9	10,501	5,917.3359	6,700.66797	37	white	23.597656	29	0.748901	0.669922	1	0	1	no	0.05	0.25	dnr after sadm	1	132	13.898438	59	10	36.09375	149.46875	3.099609	0.399963	0.899902	141	7.529297	215	17	1,494	null	6	<2 mo. follow-up	6
7,713	71.45496	1	female	0	19	345	ARF/MOSF w/Sepsis	ARF/MOSF	4	null	under $11k	9	22,573	null	null	18	white	28.296875	57	0.674927	0.579956	1	0	1	no	0.5	0.1	dnr after sadm	2	113	7.099609	80	20	36.5	null	4.699219	1.199951	2.899902	135	null	319	47	5,200	null	7	null	7
7,714	62.94299	0	male	0	9	381	COPD	COPD/CHF/Cirrhosis	5	11	under $11k	9	17,524	10,476.25	12,061.3828	19.5	black	23.5	41	0.814941	0.699951	1	1	0	no	0.95	0.8	no dnr	9	116	14.099609	130	35	38.19531	218.28125	4.199219	0.799927	0.799927	133	7.479492	162	12	1,980	0	0	no(M2 and SIP pres)	0
7,715	65.93597	1	male	0	10	154	Cirrhosis	COPD/CHF/Cirrhosis	4	9	under $11k	0	22,260	null	null	36	white	24.699219	42	0.662964	0.487976	1	0	0	no	0.5	0.4	no dnr	10	113	null	77	26	36	205.59375	3.599609	0.299988	0.799927	137	7.30957	190	14	1,350	1	0	SIP>=30	0
7,716	80.03796	1	male	0	7	180	CHF	COPD/CHF/Cirrhosis	4	9	under $11k	0	7,385	null	null	6.5	black	14.5	22	0.875977	0.792969	1	0	0	no	0.6	0.4	no dnr	7	68	10.298828	110	24	35.29688	172.5	2.399902	1.299805	0.699951	139	7.489258	204	23	2,260	1	6	adl>=4 (>=5 if sur)	6
7,717	35.01999	0	male	0	4	365	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	0	5,801	null	null	13	white	22.199219	16	0.939941	0.897949	1	0	0	no	null	null	no dnr	4	138	17	110	28	36.09375	226.65625	4	0.799927	1.099854	142	7.389648	150	21	null	1	0	no(M2 and SIP pres)	0
7,718	71.79999	0	male	0	23	363	ARF/MOSF w/Sepsis	ARF/MOSF	2	18	>$50k	41	30,752	null	null	24	white	30.296875	35	0.453979	0.334961	2	0	1	no	0.8	0.7	no dnr	23	68	8.898438	124	24	36.79688	417.375	3.299805	0.399963	1.199951	134	7.429688	94	23	1,300	null	5	adl>=4 (>=5 if sur)	5
7,719	21.37999	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	44,161	null	null	75	white	34.898438	61	0.785889	0.716919	2	0	0	no	0.15	0.15	dnr after sadm	8	108	21.5	84	24	36.29688	265	3.699707	0.799927	2.199707	134	7.429688	154	31	null	null	0	<2 mo. follow-up	0
7,720	66.41797	1	male	0	8	358	Cirrhosis	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	6,424	null	null	8.5	white	16.597656	15	0.805908	0.68689	1	1	0	no	0.7	0.7	no dnr	8	121	48	126	20	34.29688	null	2.699707	null	0.799927	145	null	141	11	null	null	5	SIP>=30	5
7,721	60.62698	0	female	0	14	361	COPD	COPD/CHF/Cirrhosis	3	8	under $11k	0	21,111	null	null	13	white	20.597656	34	0.876953	0.795898	1	0	0	no	null	null	no dnr	14	81	8.398438	64	20	36.89844	null	1.799805	3.699707	0.699951	132	null	101	3	1,800	2	3	null	3
7,722	84.50696	1	female	1	71	71	Coma	Coma	2	null	under $11k	0	162,084	null	null	41.5	black	24	33	0.406982	0.332947	14	0	0	no	0.6	0.45	dnr after sadm	45	103	19.199219	66	20	38.59375	null	2.699707	1	1.899902	128	null	116	36	1,550	null	4	adl>=4 (>=5 if sur)	4
7,723	53.29797	0	female	0	33	360	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	under $11k	37	48,988	null	null	19	white	16.699219	10	0.840942	0.786987	2	0	0	no	0.9	0.9	dnr after sadm	13	53	9.5	107	40	36.39844	280.3125	2.599609	0.5	0.599976	131	7.469727	96	12	3,035	null	0	adl>=4 (>=5 if sur)	0
7,724	37.69998	0	male	0	7	360	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	0	13,431	null	null	12	white	23.5	32	0.927979	0.876953	1	0	0	no	0.8	0.75	no dnr	7	142	19.296875	130	12	36.5	418.625	1.799805	1.199951	10	138	7.359375	79	80	2,136	0	null	no(M2 and SIP pres)	0.494751
7,725	24.57199	0	female	0	37	360	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	under $11k	0	107,908	null	null	44.75	black	23.296875	28	0.911987	0.879883	1	0	0	no	0.7	0.7	no dnr	37	67	0.799927	72	20	38.89844	null	null	0.5	1	133	null	145	7	2,550	0	0	SIP>=30	0
7,726	54.91299	1	male	0	13	340	CHF	COPD/CHF/Cirrhosis	4	9	under $11k	0	24,833	null	null	22	white	20.199219	37	0.866943	0.778931	4	1	0	no	0.5	0.4	no dnr	13	66	28.199219	107	20	34.89844	271.375	1.399902	0.799927	0.5	130	7.369141	147	17	1,983	6	6	SIP>=30	6
7,727	33.96597	0	male	0	11	358	Coma	Coma	1	12	under $11k	37	34,737	null	null	14.5	white	20.597656	11	0.731934	0.682983	5	0	0	yes	0.9	0.9	no dnr	11	49	10.699219	107	24	35.89844	null	1.599854	9.199219	1.299805	137	null	25	58	null	null	4	no(M2 and SIP pres)	4
7,728	59.754	1	male	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	50,528	null	null	41.5	white	28.296875	46	0.696899	0.606934	9	0	0	no	0.4	0.25	dnr after sadm	1	103	17.199219	136	32	39.29688	247.59375	3.099609	0.5	0.699951	133	7.5	72	9	1,275	null	7	<2 mo. follow-up	7
7,729	42.883	0	male	0	31	356	COPD	COPD/CHF/Cirrhosis	5	12	under $11k	0	59,667	null	null	28.25	white	15.398438	37	0.954956	0.921997	1	0	0	no	0.8	0.8	no dnr	31	73	9.5	100	20	37.69531	null	3.299805	0.599976	2	136	null	125	43	2,050	null	5	no(M2 and SIP pres)	5
7,730	62.44199	1	male	0	4	193	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	9	3,378	null	null	6	black	21.597656	23	0.832886	0.726929	1	0	0	no	0.7	0.7	no dnr	4	101	16	93	32	36.79688	null	3	1.399902	2.199707	134	null	168	48	1,975	0	null	null	0.494751
7,731	60.89499	1	male	0	3	194	Lung Cancer	Cancer	1	12	under $11k	0	2,920	null	null	null	white	15.199219	16	0.750977	0.491943	1	0	0	metastatic	1	0.8	no dnr	3	82	11.199219	72	20	36.09375	521.5	2	4.5	0.699951	127	7.519531	178	11	850	0	null	no(M2 and SIP pres)	0.494751
7,732	68.20294	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	5	10	null	0	17,767	null	null	null	white	53.898438	115	0.075989	0.028	1	1	0	no	0.05	0.05	dnr after sadm	3	134	14.699219	148	8	36.79688	160.96875	null	null	0.599976	126	7.429688	165	3	2,265	null	null	<2 mo. follow-up	4.164063
7,733	67.17297	0	male	0	4	355	CHF	COPD/CHF/Cirrhosis	4	3	under $11k	0	3,384	null	null	7	black	18.597656	25	0.869995	0.783936	1	1	0	no	0.7	0.3	no dnr	4	69	5.799805	76	24	36.19531	308.0625	3.699707	1.399902	1.599854	137	7.439453	112	14	null	5	null	SIP>=30	3.854981
7,734	71.35895	1	male	0	15	79	ARF/MOSF w/Sepsis	ARF/MOSF	6	12	under $11k	0	33,683	null	null	29.333328	white	23.296875	40	0.794922	0.727905	1	0	0	no	0.9	0.85	no dnr	15	100	14.798828	65	10	38.09375	254.65625	null	null	1	149	7.359375	280	29	1,712	null	5	null	5
7,735	58.17398	0	female	0	3	355	CHF	COPD/CHF/Cirrhosis	1	9	under $11k	0	2,640	null	null	null	white	15.599609	14	0.91394	0.85498	1	1	0	no	1	1	no dnr	3	79	7.899414	80	22	36.09375	null	2.199707	5.299805	2.199707	132	null	164	52	450	1	null	no(M2 and SIP pres)	1.166748
7,736	59.70999	0	male	0	18	351	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	44	44,170	null	null	31	white	25.796875	69	0.657959	0.55896	1	0	0	no	0.9	0.9	no dnr	18	133	9.298828	72	12	36	385.6875	1.699951	15	6.599609	145	7.289062	183	59	2,490	null	0	adl>=4 (>=5 if sur)	0
7,737	65.45099	1	female	0	7	9	MOSF w/Malig	ARF/MOSF	1	15	$11-$25k	0	6,485	null	null	9.5	white	30.398438	30	0.462952	0.343994	1	0	0	metastatic	0.8	0.6	dnr after sadm	1	111	17.699219	142	28	39	334.8125	2.5	0.699951	2.599609	146	7.329102	182	43	3,735	1	6	<2 mo. follow-up	6
7,738	69.19098	0	female	0	33	351	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	0	80,869	null	null	46	white	33	48	0.61792	0.512939	1	0	0	no	0.9	0.85	no dnr	33	63	18.796875	64	18	36.39844	null	4.199219	0.899902	1.199951	139	null	175	27	875	null	2	SIP>=30	2
7,739	57.88397	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$25-$50k	9	301,188	null	null	54	black	41.5	94	0.266968	0.159973	137	1	0	no	0.5	0.4	dnr after sadm	8	67	12.599609	104	10	36	191.40625	2	1	1.399902	149	7.379883	338	22	8,040	null	0	<2 mo. follow-up	0
7,740	72.23798	0	female	0	6	349	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	7,178	null	null	13	white	26.296875	19	0.731934	0.579956	1	0	0	no	0.8	0.7	no dnr	6	63	11.5	103	12	39.89844	170	null	null	0.699951	141	7.459961	93	13	1,762	1	null	null	1.166748
7,741	59.56998	0	male	0	4	347	CHF	COPD/CHF/Cirrhosis	3	9	under $11k	0	3,941	null	null	13	white	18.296875	14	0.890991	0.817993	1	1	0	no	0.7	0.4	no dnr	4	69	9.5	106	24	35.79688	271.875	2.399902	0.899902	0.799927	148	7.40918	315	12	4,685	1	1	no(M2 and SIP pres)	1
7,742	79.76697	0	female	0	13	346	CHF	COPD/CHF/Cirrhosis	2	null	under $11k	0	13,791	null	null	9.5	white	16.699219	23	0.853882	0.759888	1	1	0	no	0.8	0.8	no dnr	13	126	14.699219	65	10	39.09375	317.6875	2.399902	0.699951	0.799927	142	7.379883	120	9	2,653	0	0	no(M2 and SIP pres)	0
7,743	64.62994	1	male	0	3	298	COPD	COPD/CHF/Cirrhosis	7	16	$11-$25k	0	7,279	null	null	31	white	21.097656	30	0.85498	0.759888	1	1	0	no	0.8	0.75	no dnr	3	55	17.296875	66	6	36.59375	251.40625	2.199707	0.399963	4.099609	144	7.399414	279	58	1,418	2	null	SIP>=30	1.838867
7,744	39.84399	1	male	0	6	76	Cirrhosis	COPD/CHF/Cirrhosis	2	null	null	9	4,983	null	null	14	white	23.199219	16	0.826904	0.718994	1	0	0	no	0.9	0.7	no dnr	6	133	10.699219	75	27	37.59375	null	null	null	0.799927	139	null	130	25	2,300	null	null	null	3.559082
7,745	62.17099	0	male	0	7	344	Cirrhosis	COPD/CHF/Cirrhosis	2	14	under $11k	0	7,050	null	null	8	white	14	11	0.856934	0.763916	1	1	0	no	0.9	0.8	no dnr	7	85	11	72	20	36.79688	null	2.899902	1.299805	0.899902	133	null	114	7	null	0	0	no(M2 and SIP pres)	0
7,746	78.198	1	female	1	20	20	MOSF w/Malig	ARF/MOSF	2	12	under $11k	37	18,591	null	null	24.666656	white	28.097656	69	0.398987	0.279968	1	1	0	yes	0	0	dnr after sadm	2	118	9.699219	70	24	36.19531	200	3.299805	1.099854	1.199951	137	7.349609	441	23	4,465	null	6	<2 mo. follow-up	6
7,747	76.07898	1	male	0	3	4	Coma	Coma	0	null	null	55	2,946	2,442.3652	0	26	white	23.597656	43	0.334961	0.261963	1	0	0	no	0.1	0.001	dnr after sadm	1	125	10.898438	130	44	39.19531	206.65625	3.599609	0.399963	0.899902	143	7.589844	null	null	null	null	null	<2 mo. follow-up	1.999023
7,748	83.66296	0	male	0	6	2,029	CHF	COPD/CHF/Cirrhosis	2	8	under $11k	0	2,453	2,665.6504	0	6	white	17.796875	29	0.827881	0.719971	1	0	0	no	0.99	0.95	dnr after sadm	1	76	9.898438	63	24	35.79688	366.625	null	null	1.299805	139	7.469727	null	null	null	0	1	no(M2 and SIP pres)	1
7,749	75.01196	1	male	0	15	372	CHF	COPD/CHF/Cirrhosis	3	12	null	0	13,287	11,490.5469	0	7.666664	white	23.296875	48	0.783936	0.653931	1	1	0	no	0.9	0.75	dnr after sadm	1	109	10.298828	73	28	36.39844	276.1875	null	1.099854	3.699707	139	7.449219	null	null	null	0	0	no(M2 and SIP pres)	0
7,750	78.65594	1	female	0	20	1,439	ARF/MOSF w/Sepsis	ARF/MOSF	2	17	null	0	31,977	25,987.8906	0	28.333328	white	19.398438	33	0.7229	0.637939	10	1	0	yes	0.6	0.4	no dnr	20	113	8.898438	103	24	39.19531	222.5	2.399902	0.599976	1.5	131	7.509766	null	null	null	null	0	no(M2 and SIP pres)	0
7,751	64.758	1	male	0	5	790	Lung Cancer	Cancer	1	null	null	0	3,078	2,769.9531	0	11	white	21.898438	36	0.5979	0.279968	1	0	0	metastatic	0.9	0.9	no dnr	5	61	4.299805	130	28	38.79688	null	null	null	1.599854	136	null	null	null	null	null	null	null	2.161621
7,752	73.88397	1	male	0	5	773	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	3,335	3,146.0723	0	14	white	17	11	0.820923	0.708984	1	0	0	yes	0.9	0.8	no dnr	5	99	12.398438	52	24	36.39844	320	3.799805	1.099854	1.199951	142	7.449219	null	null	null	0	null	no(M2 and SIP pres)	0.4948
7,753	70.771	1	female	0	4	192	Colon Cancer	Cancer	1	null	null	0	1,922	1,871.2832	0	10	white	11.798828	22	0.868896	0.705933	1	0	0	metastatic	0.8	0.5	no dnr	4	111	5	73	18	36.59375	null	3.899902	0.299988	1.199951	130	null	null	null	null	null	null	null	1.607666
7,754	61.478	0	male	0	41	2,020	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	under $11k	0	51,744	47,658.8438	0	19.75	white	22.796875	37	0.806885	0.74292	4	0	0	no	null	null	no dnr	41	55	21.699219	66	12	36.69531	182.84375	3.199707	0.899902	1.299805	140	7.469727	null	null	null	null	0	no(M2 and SIP pres)	0
7,755	73.27295	1	male	0	7	66	Lung Cancer	Cancer	2	10	under $11k	0	4,365	4,049.3203	0	18	white	35.09375	43	0.196991	0.017998	1	0	0	metastatic	0.9	0.1	dnr after sadm	1	65	11.199219	63	26	34.89844	366.625	2.399902	0.599976	0.799927	134	7.509766	null	null	null	3	1	null	1
7,756	55.198	1	male	0	26	552	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	$11-$25k	9	57,924	44,915.9375	0	25.25	white	18.597656	19	0.838989	0.783936	12	0	0	no	0.7	0.7	no dnr	26	110	18.898438	106	10	38	270	3.699707	0.799927	1.199951	145	7.469727	null	null	null	null	0	adl>=4 (>=5 if sur)	0
7,757	67.10999	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	$11-$25k	44	74,747	51,656.3438	0	53.5	white	28.699219	66	0.43396	0.313965	13	1	0	no	0	0	dnr after sadm	1	69	26.699219	108	22	39.09375	250	4.599609	3.699707	5.699219	144	7.359375	null	null	null	null	0	<2 mo. follow-up	0
7,758	66.79498	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	26	17,599	14,781.3359	0	21.5	white	24.898438	32	0.628906	0.525879	11	0	0	no	0.2	0.2	no dnr	10	115	24.398438	120	28	37.79688	192.5	3.299805	1.099854	1.399902	145	7.489258	null	null	null	null	null	<2 mo. follow-up	2.285156
7,759	26.73499	0	male	0	7	2,016	MOSF w/Malig	ARF/MOSF	1	12	$11-$25k	0	9,401	7,158.1367	0	19	white	39.296875	67	0.336975	0.220978	2	0	0	yes	0.98	0.97	no dnr	7	75	0.299988	64	32	36.29688	120	null	null	3.399902	137	7.419922	null	null	null	0	0	no(M2 and SIP pres)	0
7,760	67.46594	1	male	0	12	60	Lung Cancer	Cancer	1	8	null	0	5,886	6,097.1445	0	8	white	21.597656	18	0.5979	0.278992	1	0	0	metastatic	0.5	0.1	dnr after sadm	4	109	4.199219	100	24	35.5	null	3.199707	0.299988	1.099854	136	null	null	null	null	0	0	null	0
7,761	73.95197	1	male	0	5	399	COPD	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	2,538	2,126.2324	0	14	white	25	18	0.743896	0.596924	1	0	0	no	0.9	0.8	no dnr	5	108	9.5	110	24	37	285.125	null	null	0.699951	125	7.419922	null	null	null	1	2	no(M2 and SIP pres)	2
7,762	74.75195	1	female	0	19	336	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	10,244	11,008.7188	0	10	white	22.699219	35	0.793945	0.668945	1	0	0	no	0.8	0.5	no dnr	19	69	10.298828	93	22	35.69531	295.1875	3.299805	1.099854	1.299805	130	7.469727	null	null	null	0	4	no(M2 and SIP pres)	4
7,763	65.69196	1	male	0	25	26	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	206,035	79,364.5625	-102.71997	38.25	white	28.898438	63	0.61792	0.513916	69	0	0	no	0.3	0.1	dnr after sadm	24	151	15.798828	146	32	39.19531	282	2.199707	0.899902	4.599609	141	7.429688	null	null	null	null	null	<2 mo. follow-up	2.108887
7,764	69.28094	1	male	0	10	53	Colon Cancer	Cancer	1	8	under $11k	0	8,684	7,511.8164	0	18	white	23	21	0.707886	0.424988	1	0	0	metastatic	0.99	0.51	no dnr	10	128	12.5	116	20	35.39844	null	null	1.399902	1.099854	139	null	null	null	null	1	2	<2 mo. follow-up	2
7,765	83.30695	1	male	0	9	167	Cirrhosis	COPD/CHF/Cirrhosis	2	8	null	55	3,965	4,165.9961	0	8.5	white	16.199219	31	0.464966	0.262939	1	0	0	no	0.7	0.6	dnr after sadm	1	73	7.5	76	20	36.89844	371.375	2.599609	2.599609	1.5	139	7.619141	null	null	null	null	1	no(M2 and SIP pres)	1
7,766	81.44299	0	female	0	6	2,009	CHF	COPD/CHF/Cirrhosis	2	8	null	0	2,281	2,301.5898	0	14	white	18.898438	26	0.821899	0.709961	1	1	0	no	0.8	0.8	no dnr	6	83	8.798828	59	24	35.69531	447.5625	null	0.899902	1.5	139	7.579102	null	null	null	4	1	adl>=4 (>=5 if sur)	1
7,767	54.93198	1	female	0	5	107	Lung Cancer	Cancer	2	8	null	0	2,899	2,545.9961	0	7	white	17.398438	14	0.7229	0.447998	1	0	0	metastatic	0.5	0.1	no dnr	5	96	20.597656	83	24	35.39844	null	3.699707	0.299988	0.899902	133	null	null	null	null	0	null	null	0.4948
7,768	21.92699	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	100	8,477	5,827.5898	0	41	white	59.195313	85	0.001	0	2	0	0	no	null	null	dnr after sadm	3	33	1.699951	170	30	39	55	3.099609	1.299805	2.099609	142	7.269531	null	null	null	null	null	<2 mo. follow-up	2.424805
7,769	72.33398	0	male	0	6	2,006	CHF	COPD/CHF/Cirrhosis	2	12	>$50k	0	2,239	2,402.2305	0	6	white	15.298828	28	0.886963	0.81189	1	1	0	no	0.9	0.5	no dnr	6	99	7.899414	60	20	35.79688	257.125	4.199219	0.699951	1.699951	143	7.439453	null	null	null	0	0	no(M2 and SIP pres)	0
7,770	82.96198	1	male	0	5	6	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	44	9,456	7,077.1641	0	26	white	35.195313	63	0.142975	0.067993	2	0	0	yes	0	0	dnr after sadm	1	127	13.798828	148	50	40.09375	100	null	null	1.099854	147	7.269531	null	null	null	null	0	<2 mo. follow-up	0
7,771	43.603	1	female	0	92	1,356	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	83,252	69,330.625	2,246.68945	26	white	27.296875	25	0.817993	0.756958	2	0	0	no	0.9	0.9	dnr after sadm	48	121	14.199219	102	22	38.79688	80	null	null	0.799927	137	7.40918	null	null	null	null	2	adl>=4 (>=5 if sur)	2
7,772	58.49698	1	female	0	6	134	Colon Cancer	Cancer	1	12	null	0	2,741	2,667.8516	0	13	white	15.699219	20	0.844971	0.658936	1	0	0	metastatic	0.5	0.05	no dnr	6	93	9.298828	77	22	36.59375	null	null	null	1.5	136	null	null	null	null	2	4	no(M2 and SIP pres)	4
7,773	59.01199	1	male	0	61	77	CHF	COPD/CHF/Cirrhosis	1	12	$25-$50k	37	81,821	63,425.1875	0	36	white	26.699219	45	0.68396	0.514893	1	0	0	no	0.9	0.9	no dnr	61	75	17.699219	135	40	39.19531	176	4	1.299805	1.699951	145	7.459961	null	null	null	null	0	adl>=4 (>=5 if sur)	0
7,774	69.57697	1	female	1	23	23	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	$11-$25k	9	53,794	36,784.875	0	43	white	32.695313	54	0.581909	0.471985	1	0	0	no	0.25	0.25	dnr after sadm	18	101	27.398438	102	22	37.19531	83.0625	2.299805	0.5	2.699707	134	7.339844	null	null	null	null	0	<2 mo. follow-up	0
7,775	34.83899	0	female	0	29	1,999	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	22,063	19,388.7031	0	9.75	white	18.199219	15	0.927979	0.901978	1	0	0	no	0.9	0.9	no dnr	29	72	10.898438	58	24	38.79688	null	5	0.5	0.699951	135	null	null	null	null	null	7	adl>=4 (>=5 if sur)	7
7,776	77.06494	1	female	0	16	1,539	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	0	8,666	9,628.8203	0	12.666664	white	25.097656	45	0.744995	0.598999	1	1	0	no	0.3	0.3	no dnr	16	69	9.298828	114	24	35	380.9375	3.799805	0.5	2.399902	136	7.529297	null	null	null	1	0	null	0
7,777	69.862	1	male	1	18	18	Coma	Coma	2	12	$11-$25k	100	63,622	46,171.6562	0	48.666657	white	34.09375	71	0.001	0	18	0	0	yes	0.2	0.1	dnr after sadm	4	118	23.898438	140	46	39.69531	240	2.299805	3.799805	2.099609	130	7.479492	null	null	null	null	0	<2 mo. follow-up	0
7,778	70.29999	0	female	0	13	1,995	Cirrhosis	COPD/CHF/Cirrhosis	2	13	null	0	7,277	6,996.793	0	8.5	white	16.597656	37	0.783936	0.654907	1	0	0	no	0.1	0.001	no dnr	13	76	null	74	24	37.89844	271.375	2.299805	4.5	0.899902	134	7.519531	null	null	null	3	null	null	2.511099
7,779	41.50299	1	male	0	6	1,036	Lung Cancer	Cancer	1	14	$25-$50k	0	2,684	2,610.9629	0	6	white	13.398438	6	0.814941	0.601929	1	0	0	metastatic	0.9	0.75	no dnr	6	102	null	76	20	36.79688	null	null	null	null	140	null	null	null	null	0	0	no(M2 and SIP pres)	0
7,780	50.10797	1	male	0	4	5	COPD	COPD/CHF/Cirrhosis	0	8	under $11k	0	2,082	1,808.2393	0	7	white	22.199219	26	0.844971	0.744995	1	0	0	metastatic	null	null	dnr after sadm	1	116	null	130	40	36.39844	null	null	null	null	140	null	null	null	null	2	0	<2 mo. follow-up	0
7,781	77.25897	1	male	0	21	1,699	CHF	COPD/CHF/Cirrhosis	2	8	under $11k	0	16,185	14,571.4766	0	13	white	18.699219	31	0.838989	0.736938	1	1	0	no	null	null	no dnr	21	99	6.299805	64	32	36.29688	244	3.599609	0.899902	1.699951	137	7.399414	null	null	null	1	3	no(M2 and SIP pres)	3
7,782	75.56494	1	female	0	21	1,152	ARF/MOSF w/Sepsis	ARF/MOSF	0	9	null	0	34,520	27,436.7031	0	16	white	23.097656	34	0.724976	0.640991	9	0	0	no	0.95	0.99	no dnr	21	121	8.599609	52	8	38.39844	195.90625	2.299805	0.699951	4.199219	135	7.379883	null	null	null	null	4	adl>=4 (>=5 if sur)	4
7,783	63.12097	1	male	0	13	39	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	17,871	16,333.0469	-28.48	21.5	white	27.296875	35	0.691895	0.599976	14	0	0	no	0.9	0.7	no dnr	13	150	11.099609	56	16	35.59375	null	null	null	3.899902	138	null	null	null	null	0	0	<2 mo. follow-up	0
7,784	39.25497	1	female	0	158	700	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	>$50k	0	238,874	186,060.625	77,000.875	23	white	30.097656	62	0.775879	0.702881	4	0	0	no	null	null	no dnr	158	50	11.298828	155	30	38.69531	null	null	null	12.898438	136	null	null	null	null	null	0	null	0
7,785	61.19397	1	male	0	12	214	CHF	COPD/CHF/Cirrhosis	3	24	>$50k	0	6,472	6,969.9648	0	8	white	22.898438	26	0.840942	0.738892	1	1	0	no	0.9	0.5	no dnr	12	71	10.398438	59	24	36	380.9375	3.799805	1.699951	1.5	127	7.419922	null	null	null	0	1	no(M2 and SIP pres)	1
7,786	74.396	1	male	0	5	917	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	2,389	2,352.4883	0	5	white	25.097656	33	0.736938	0.586914	1	0	0	no	0.95	0.9	dnr after sadm	2	64	16.5	118	24	36.79688	216	3.099609	0.399963	1.199951	131	7.429688	null	null	null	5	6	null	6
7,787	59.02298	1	female	0	9	496	CHF	COPD/CHF/Cirrhosis	2	null	null	0	5,395	5,061.0938	0	9.5	white	12.599609	18	0.930908	0.882935	1	0	0	no	0.95	0.95	no dnr	9	79	6.799805	73	24	37.69531	309.5	null	null	1	139	7.479492	null	null	null	null	null	null	2.254395
7,788	88.82697	1	female	0	5	207	CHF	COPD/CHF/Cirrhosis	1	8	under $11k	0	1,944	2,102.9981	0	12	white	15.298828	23	0.841919	0.741943	1	0	0	no	null	null	dnr after sadm	1	64	4.399414	59	24	36.29688	null	3.699707	0.799927	1.299805	139	null	null	null	null	null	0	no(M2 and SIP pres)	0
7,789	60.26297	0	male	0	16	1,988	Coma	Coma	2	12	null	100	22,661	16,517.4375	0	26.333328	white	27.398438	44	0.163971	0.109985	1	0	0	no	0.2	0.1	no dnr	16	111	12.199219	120	8	38	130	2.599609	1.599854	1.399902	133	7.539062	null	null	null	null	1	no(M2 and SIP pres)	1
7,790	81.41296	1	male	0	7	41	COPD	COPD/CHF/Cirrhosis	4	7	under $11k	0	5,227	4,446.5977	0	33	white	36.398438	53	0.289978	0.11499	1	1	0	yes	0.9	0.9	dnr before sadm	-1	69	16.796875	118	32	37.29688	81.625	3.299805	0.299988	1.299805	126	7.379883	null	null	null	null	2	<2 mo. follow-up	2
7,791	68.96399	0	male	0	14	1,990	COPD	COPD/CHF/Cirrhosis	1	12	null	0	9,267	9,465.5312	0	9.666664	white	17.898438	29	0.868896	0.782959	1	0	0	no	0.9	0.75	no dnr	14	114	8.599609	43	28	37.89844	202.84375	3.699707	0.599976	1.199951	140	7.40918	null	null	null	1	null	no(M2 and SIP pres)	1.1669
7,792	72.28497	0	male	0	68	1,988	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	null	0	71,553	59,249.6562	518.61963	24	white	20.199219	30	0.80188	0.735962	5	0	0	no	0.6	0.6	no dnr	68	117	12.699219	68	46	39.19531	288.5625	3.099609	2.399902	1	145	7.449219	null	null	null	null	0	null	0
7,793	69.25098	0	female	0	6	1,987	COPD	COPD/CHF/Cirrhosis	2	null	null	0	2,644	2,685.9668	0	12	white	16.199219	17	0.882935	0.805908	1	0	0	no	0.75	0.5	no dnr	6	69	null	76	24	36	217.375	null	null	0.799927	141	7.349609	null	null	null	null	null	null	3.02002
7,794	63.392	1	female	0	5	105	Lung Cancer	Cancer	1	8	$11-$25k	0	2,787	2,425.0137	0	7	white	8	10	0.848999	0.666992	1	0	0	metastatic	0.8	0.2	no dnr	5	102	7.299805	76	20	36.59375	null	4	0.399963	0.899902	136	null	null	null	null	0	1	no(M2 and SIP pres)	1
7,795	72.20795	1	female	0	8	31	Colon Cancer	Cancer	1	null	null	0	3,755	4,024.25	0	9.5	white	10.898438	11	0.875	0.717896	1	0	0	metastatic	0.75	0.1	no dnr	8	84	9.398438	81	24	36.19531	null	3.799805	0.299988	1	137	null	null	null	null	null	null	<2 mo. follow-up	2.074707
7,796	71.64996	1	male	1	50	50	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	$25-$50k	0	133,354	92,709.3125	0	45	white	26	38	0.623901	0.519897	8	0	0	yes	null	null	dnr after sadm	45	61	18.898438	116	8	36.59375	253.3125	2.899902	1.299805	7.199219	141	7.419922	null	null	null	null	6	<2 mo. follow-up	6
7,797	77.112	1	male	0	60	465	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	41	110,668	81,567.25	0	32.5	white	29.796875	48	0.359985	0.242981	9	1	0	no	0.9	0.8	dnr after sadm	32	110	20.5	120	34	38.79688	152	null	null	1.899902	135	7.489258	null	null	null	null	null	null	3.00293
7,798	64.39996	1	female	0	18	963	COPD	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	15,896	13,637.4609	0	16.333328	white	23.097656	9	0.831909	0.725952	1	0	0	no	0.9	0.5	no dnr	18	95	14.099609	104	20	36.59375	224.4375	3.299805	0.699951	0.599976	132	7.469727	null	null	null	null	1	no(M2 and SIP pres)	1
7,799	29.06799	0	male	0	41	1,984	Coma	Coma	1	19	$25-$50k	9	50,502	42,701.6875	0	24.75	white	28.699219	46	0.746948	0.699951	8	0	0	no	0.3	0.3	no dnr	41	65	20.898438	130	32	35.59375	350	2	0.599976	1	128	7.5	null	null	null	null	3	adl>=4 (>=5 if sur)	3
7,800	84.271	1	female	1	5	5	COPD	COPD/CHF/Cirrhosis	1	12	null	26	2,439	2,348.707	0	13	white	14.798828	36	0.762939	0.623901	1	0	0	no	0.05	0.000125	dnr before sadm	-1	69	9.298828	80	44	36.39844	285.125	4.099609	0.399963	0.599976	143	7.189453	null	null	null	null	3	<2 mo. follow-up	3

Subsets and Splits